BARBALISCIA, SILVIA
BARBALISCIA, SILVIA
Dipartimento di Medicina Sperimentale
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?
2018-01-01 Di Maio, Vc; Cento, V; Aragri, M; Paolucci, S; Pollicino, T; Coppola, N; Bruzzone, B; Ghisetti, V; Zazzi, M; Brunetto, M; Bertoli, A; Barbaliscia, S; Galli, S; Gennari, W; Baldanti, F; Raimondo, G; Perno, Cf; Ceccherini-Silberstein, F
Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b
2021-01-01 Alkhatib, M; DI MAIO, Vc; De Murtas, V; Polilli, E; Milana, M; Teti, E; Fiorentino, G; Calvaruso, V; Barbaliscia, S; Bertoli, A; Scutari, R; Carioti, L; Cento, V; Santoro, M; Orro, A; Maida, I; Lenci, I; Sarmati, L; Craxì, A; Pasquazzi, C; Parruti, G; Babudieri, S; Milanesi, L; Andreoni, M; Angelico, M; Perno, Cf; CECCHERINI SILBERSTEIN, F; Svicher, V; Salpini, R
Impact of analytical treatment interruption on burden and diversification of HIV peripheral reservoir: a pilot study
2021-07-19 Scutari, R; Costabile, V; Galli, L; Bellocchi, Mc; Carioti, L; Barbaliscia, S; Poli, A; Galli, A; Perno, Cf; Santoro, M; Castagna, A; Ceccherini Silberstein, F; Alteri, C; Spagnuolo, V
NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients
2019-01-01 Bellocchi, Mc; Aragri, M; Carioti, L; Fabeni, L; Pipitone, Rm; Brancaccio, G; Sorbo, Mc; Barbaliscia, S; Di Maio, Vc; Bronte, F; Grimaudo, S; Mazzucco, W; Frigeri, F; Cantone, M; Pinto, A; Perno, Cf; Craxì, A; Gaeta, Gb; Di Marco, V; Ceccherini-Silberstein, F
Optimal cure rate by personalized HCV regimens in real-life: a proof-of-concept study
2017-09-18 Cento, V; Aragri, M; Teti, E; Polilli, E; Bertoli, A; Foroghi, L; Barbaliscia, S; DI MAIO, Vc; Pieri, A; Pace Palitti, V; Sarmati, L; Parruti, G; Andreoni, M; Perno, Cf; CECCHERINI SILBERSTEIN, F
Prevalence of resistance-associated substitutions to NS3, NS5A and NS5B inhibitors at DAA-failure in hepatitis C virus in Italy from 2015 to 2019
2021-06-01 Rossetti, B; Paglicci, L; Di Maio, Vc; Cassol, C; Barbaliscia, S; Paolucci, S; Bruzzone, B; Coppola, N; Montagnani, F; Micheli, V; Monno, L; Zanelli, G; Santantonio, T; Cuomo, N; Caudai, C; Zazzi, M; Ceccherini-Silberstein, F; On Behalf Of The Hcv Virology Italian Resistance Network Vironet, C
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C
2021-08-04 DI MAIO, Vc; Barbaliscia, S; Teti, E; Fiorentino, G; Milana, M; Paolucci, S; Pollicino, T; Morsica, G; Starace, M; Bruzzone, B; Gennari, W; Micheli, V; Yu La Rosa, K; Foroghi, L; Calvaruso, V; Lenci, I; Polilli, E; Babudieri, S; Aghemo, A; Raimondo, G; Sarmati, L; Coppola, N; Pasquazzi, C; Baldanti, F; Parruti, G; Perno, Cf; Angelico, M; Craxì, A; Andreoni, M; CECCHERINI SILBERSTEIN, F; Virology Italian Resistance Network Group (Vironet C), H
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2018 | Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? | Di Maio, Vc; Cento, V; Aragri, M; Paolucci, S; Pollicino, T; Coppola, N; Bruzzone, B; Ghisetti, V; Zazzi, M; Brunetto, M; Bertoli, A; Barbaliscia, S; Galli, S; Gennari, W; Baldanti, F; Raimondo, G; Perno, Cf; Ceccherini-Silberstein, F | Articolo su rivista | |
| 1-gen-2021 | Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b | Alkhatib, M; DI MAIO, Vc; De Murtas, V; Polilli, E; Milana, M; Teti, E; Fiorentino, G; Calvaruso, V; Barbaliscia, S; Bertoli, A; Scutari, R; Carioti, L; Cento, V; Santoro, M; Orro, A; Maida, I; Lenci, I; Sarmati, L; Craxì, A; Pasquazzi, C; Parruti, G; Babudieri, S; Milanesi, L; Andreoni, M; Angelico, M; Perno, Cf; CECCHERINI SILBERSTEIN, F; Svicher, V; Salpini, R | Articolo su rivista | |
| 19-lug-2021 | Impact of analytical treatment interruption on burden and diversification of HIV peripheral reservoir: a pilot study | Scutari, R; Costabile, V; Galli, L; Bellocchi, Mc; Carioti, L; Barbaliscia, S; Poli, A; Galli, A; Perno, Cf; Santoro, M; Castagna, A; Ceccherini Silberstein, F; Alteri, C; Spagnuolo, V | Articolo su rivista | |
| 1-gen-2019 | NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients | Bellocchi, Mc; Aragri, M; Carioti, L; Fabeni, L; Pipitone, Rm; Brancaccio, G; Sorbo, Mc; Barbaliscia, S; Di Maio, Vc; Bronte, F; Grimaudo, S; Mazzucco, W; Frigeri, F; Cantone, M; Pinto, A; Perno, Cf; Craxì, A; Gaeta, Gb; Di Marco, V; Ceccherini-Silberstein, F | Articolo su rivista | |
| 18-set-2017 | Optimal cure rate by personalized HCV regimens in real-life: a proof-of-concept study | Cento, V; Aragri, M; Teti, E; Polilli, E; Bertoli, A; Foroghi, L; Barbaliscia, S; DI MAIO, Vc; Pieri, A; Pace Palitti, V; Sarmati, L; Parruti, G; Andreoni, M; Perno, Cf; CECCHERINI SILBERSTEIN, F | Articolo su rivista | |
| 1-giu-2021 | Prevalence of resistance-associated substitutions to NS3, NS5A and NS5B inhibitors at DAA-failure in hepatitis C virus in Italy from 2015 to 2019 | Rossetti, B; Paglicci, L; Di Maio, Vc; Cassol, C; Barbaliscia, S; Paolucci, S; Bruzzone, B; Coppola, N; Montagnani, F; Micheli, V; Monno, L; Zanelli, G; Santantonio, T; Cuomo, N; Caudai, C; Zazzi, M; Ceccherini-Silberstein, F; On Behalf Of The Hcv Virology Italian Resistance Network Vironet, C | Articolo su rivista | |
| 4-ago-2021 | Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C | DI MAIO, Vc; Barbaliscia, S; Teti, E; Fiorentino, G; Milana, M; Paolucci, S; Pollicino, T; Morsica, G; Starace, M; Bruzzone, B; Gennari, W; Micheli, V; Yu La Rosa, K; Foroghi, L; Calvaruso, V; Lenci, I; Polilli, E; Babudieri, S; Aghemo, A; Raimondo, G; Sarmati, L; Coppola, N; Pasquazzi, C; Baldanti, F; Parruti, G; Perno, Cf; Angelico, M; Craxì, A; Andreoni, M; CECCHERINI SILBERSTEIN, F; Virology Italian Resistance Network Group (Vironet C), H | Articolo su rivista |